PDF herunterladen
Pharmacopsychiatry 2021; 54(05): 215-223
DOI: 10.1055/a-1349-3870
Original Paper

Withanone Ameliorates Stress Symptoms in Caenorhabditis Elegans by Acting through Serotonin Receptors

Janine Naß
Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany
,
Thomas Efferth
Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

ABSTRACT

Introduction Depression is responsible for 800 000 deaths worldwide, a number that will rise significantly due to the COVID-19 pandemic. Affordable novel drugs with less severe side effects are urgently required. We investigated the effect of withanone (WN) from Withania somnifera on the serotonin system of wild-type and knockout Caenorhabditis elegans strains using in silico, in vitro, and in vivo methods.

Methods WN or fluoxetine (as positive control drug) was administered to wild-type (N2) and knockout C. elegans strains (AQ866, DA1814, DA2100, DA2109, and MT9772) to determine their effect on oxidative stress (Trolox, H2DCFDA, and juglone assays) on osmotic stress and heat stress and lifespan. Quantitative real-time RT-PCR was applied to investigate the effect of WN or fluoxetine on the expression of serotonin receptors (ser-1, ser-4, ser-7) and serotonin transporter (mod-5). The binding affinity of WN to serotonin receptors and transporter was analyzed in silico using AutoDock 4.2.6.

Results WN scavenged ROS in wild-type and knockout C. elegans and prolonged their lifespan. WN upregulated the expression of serotonin receptor and transporter genes. In silico analyses revealed high binding affinities of WN to Ser-1, Ser-4, Ser-7, and Mod-5.

Limitations Further studies are needed to prove whether the results from C. elegans are transferrable to mammals and human beings.

Conclusion WN ameliorated depressive-associated stress symptoms by activating the serotonin system. WN may serve as potential candidate in developing new drugs to treat depression.

Key words

Caenorhabditis elegans - depression - lifespan - molecular docking - stress

Supplementary Material



Publikationsverlauf

Artikel online veröffentlicht:
06. Mai 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 World Health Organization. Depression and other common mental disorders: Global health estimates; 2017; https://apps.who.int/iris/handle/10665/254610 Accessed on February 19, 2021
  • 2 Kanter JMK. COVID-19 could lead to an epidemic of clinical depression, and the health care system isn’t ready for that, either. 2020; https://theconversation.com/covid-19-could-lead-to-an-epidemic-of-clinical-depression-and-the-health-care-system-isnt-ready-for-that-either-134528. Accessed on February 19, 2021
  • 3 Zhang Y, Chen Y, Ma L. Depression and cardiovascular disease in elderly: Current understanding. J Clin Neurosci 2018; 47: 1-5
    CrossrefPubMedGoogle Scholar
  • 4 Rivera M, Porras-Segovia A, Rovira P. et al. Associations of major depressive disorder with chronic physical conditions, obesity and medication use: Results from the PISMA-ep study. Eur Psychiatry 2019; 60: 20-27
    CrossrefPubMedGoogle Scholar
  • 5 Crawford AA, Lewis S, Nutt D. et al. Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals. Psychopharmacology (Berl) 2014; 231: 2921-2931
    CrossrefPubMedGoogle Scholar
  • 6 Bellivier F, Henry C, Szöke A. et al. Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression. Neurosci Lett 1998; 255: 143-146
    CrossrefPubMedGoogle Scholar
  • 7 Yuan H, Zhu X, Luo Q. et al. Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study. Neuropsychiatr Dis Treat 2019; 15: 957-966
    CrossrefPubMedGoogle Scholar
  • 8 Li J, OW Li W. et al. Oxidative stress and neurodegenerative disorders. Int J Mol Sci 2013; 14: 24438-24475
    CrossrefPubMedGoogle Scholar
  • 9 Angelova PR, Abramov AY. Role of mitochondrial ROS in the brain: From physiology to neurodegeneration. FEBS Lett 2018; 592: 692-702
    CrossrefPubMedGoogle Scholar
  • 10 Wadhwa R, Gupta R, Maurya PK. Oxidative stress and accelerated aging in neurodegenerative and neuropsychiatric disorder. Curr Pharm Des 2018; 24: 4711-4725
    CrossrefPubMedGoogle Scholar
  • 11 Chung CP, Schmidt D, Stein CM. et al. Increased oxidative stress in patients with depression and its relationship to treatment. Psychiatry Res 2013; 206: 213-216
    CrossrefPubMedGoogle Scholar
  • 12 Maes M, Kubera M, Mihaylova I. et al. Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression. J Affect Disord 2013; 149: 23-29
    CrossrefPubMedGoogle Scholar
  • 13 Sperner-Unterweger B, Kohl C, Fuchs D. Immune changes and neurotransmitters: Possible interactions in depression?. Prog Neuropsychopharmacol Biol Psychiatry 2014; 48: 268-276
    CrossrefPubMedGoogle Scholar
  • 14 Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008; 455: 894-902
    Google Scholar
  • 15 Liu L, Liu C, Wang Y. et al. Herbal medicine for anxiety, depression and insomnia. Curr Neuropharmacol 2015; 13: 481-493
    CrossrefPubMedGoogle Scholar
  • 16 Wang Y, Li M, Liang Y. et al. Chinese herbal medicine for the treatment of depression: Applications, efficacies and mechanisms. Curr Pharm Des 2017; 23: 5180-5190
    PubMedGoogle Scholar
  • 17 Sarris J, Panossian A, Schweitzer I. et al. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol 2011; 21: 841-860
    CrossrefPubMedGoogle Scholar
  • 18 Ren Y, Zhu C, Wu J. et al. Comparison between herbal medicine and fluoxetine for depression: a systematic review of randomized controlled trials. Complement Ther Med 2015; 23: 674-684
    CrossrefPubMedGoogle Scholar
  • 19 Ismail H, Amanat MA, Iqbal A. et al. Medicinal plants: A complementary and alternative antidepressant therapy. Curr Pharm Des 2018; 24: 2609-2624
    CrossrefPubMedGoogle Scholar
  • 20 Singh N, Bhalla M, Jager Pde. et al. An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med 2011; 8: 208-213
    CrossrefPubMedGoogle Scholar
  • 21 Konar A, Shah N, Singh R. et al. Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One 2011; 6: e27265
    CrossrefPubMedGoogle Scholar
  • 22 Panossian A, Seo EJ, Efferth T. Effects of anti-inflammatory and adaptogenic herbal extracts on gene expression of eicosanoids signaling pathways in isolated brain cells. Phytomedicine 2019; 60: 152881
    CrossrefPubMedGoogle Scholar
  • 23 Garg S, Kaul SC, Wadhwa R. Anti-stress and glial differentiation effects of a novel combination of cucurbitacin B and withanone (CucWi-N): Experimental evidence. Ann Neurosci 2018; 25: 201-209
    CrossrefPubMedGoogle Scholar
  • 24 Kaletta T, Hengartner MO. Finding function in novel targets: C. elegans as a model organism. Nat Rev Drug Discov 2006; 5: 387-398
    CrossrefPubMedGoogle Scholar
  • 25 Rodriguez M, Snoek LB, Bono Mde. et al. Worms under stress: C. elegans stress response and its relevance to complex human disease and aging. Trends Genet 2013; 29: 367-374
    CrossrefPubMedGoogle Scholar
  • 26 Ding X, Njus Z, Kong T. et al. Effective drug combination for Caenorhabditis elegans nematodes discovered by output-driven feedback system control technique. Sci Adv 2017; 3: eaao1254
    CrossrefPubMedGoogle Scholar
  • 27 O’Reilly LP, Luke CJ, Perlmutter DH. et al. C. elegans in high-throughput drug discovery. Adv Drug Deliv Rev 2014; 69-70: 247-453
    CrossrefPubMedGoogle Scholar
  • 28 Ni YG, Miledi R. Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac). Proc Natl Acad Sci USA 1997; 94: 2036-2040
    CrossrefPubMedGoogle Scholar
  • 29 Zafir A, Banu N. Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats. Eur J Pharmacol 2007; 572: 23-31
    CrossrefPubMedGoogle Scholar
  • 30 Girard LR, Fiedler TJ, Harris TW. et al. WormBook: The online review of Caenorhabditis elegans biology. Nucleic Acids Res 2007; 35: D472-D475
    CrossrefPubMedGoogle Scholar
  • 31 Strange K. An overview of C. elegans biology. Methods Mol Biol 2006; 351: 1-11
    PubMedGoogle Scholar
  • 32 Wongchai K, Schlotterer A, Lin J. et al. Protective effects of liraglutide and linagliptin in C. elegans as a new model for glucose-induced neurodegeneration. Horm Metab Res 2016; 48: 70-75
    PubMedGoogle Scholar
  • 33 Miller NJ, Rice-Evans C, Davies MJ. et al. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84: 407-412
    CrossrefPubMedGoogle Scholar
  • 34 Naß J, Efferth T. Ursolic acid ameliorates stress and reactive oxygen species in C. elegans knockout mutants by the dopamine Dop1 and Dop3 receptors. Phytomedicine 2021; 81: 153439
    CrossrefPubMedGoogle Scholar
  • 35 Naß J, Abdelfatah S, Efferth T. Ursolic acid enhances stress resistance, reduces ROS accumulation and prolongs life span in C. elegans serotonin-deficient mutants. Food Funct 2021; https://doi.org/10.1039/d0fo02208j; PMID: 33596295
  • 36 Naß J, Abdelfatah S, Efferth T. Induction of stress resistance and extension of lifespan in Chaenorhabditis elegans serotonin-receptor knockout strains by withanolide A. Phytomedicine. 2021; 84: 153482
    PubMedGoogle Scholar
  • 37 Solomon A, Bandhakavi S, Jabbar S. et al. Caenorhabditis elegans OSR-1 regulates behavioral and physiological responses to hyperosmotic environments. Genetics 2004; 167: 161-170
    CrossrefPubMedGoogle Scholar
  • 38 Zevian SC, Yanowitz JL. Methodological considerations for heat shock of the nematode Caenorhabditis elegans. Methods 2014; 68: 450-457
    CrossrefPubMedGoogle Scholar
  • 39 Sutphin GL, Kaeberlein M. Measuring Caenorhabditis elegans life span on solid media. J Vis Exp 2009; 27: 1152
    PubMedGoogle Scholar
  • 40 Zhang Y, Chen D, Smith MA. et al. Selection of reliable reference genes in Caenorhabditis elegans for analysis of nanotoxicity. PLoS One 2012; 7: e31849
    CrossrefPubMedGoogle Scholar
  • 41 Kiefer F, Arnold K, Künzli M. et al. The SWISS-MODEL Repository and associated resources. Nucleic Acids Res 2009; 37: D387-D392
    CrossrefPubMedGoogle Scholar
  • 42 Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol 2015; 1263: 243-250
    Google Scholar
  • 43 Morris GM, Huey R, Lindstrom W. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009; 30: 2785-2791
    CrossrefPubMedGoogle Scholar
  • 44 Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996; 1: 33-38
    CrossrefPubMedGoogle Scholar
  • 45 Kadioglu O, Saeed ME, Valoti M. et al. Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analyses. Biochem Pharmacol 2016; 104: 42-51
    CrossrefPubMedGoogle Scholar
  • 46 Han SK, Lee D, Lee H. et al. OASIS 2: online application for survival analysis 2 with features for the analysis of maximal lifespan and healthspan in aging research. Oncotarget 2016; 7: 56147-56152
    CrossrefPubMedGoogle Scholar
  • 47 GraphPad Prism. La Jolla California USA 2020 Available from URL www.graphpad.com
  • 48 Huether G, Fettkötter I, Keilhoff G. et al. Serotonin acts as a radical scavenger and is oxidized to a dimer during the respiratory burst of activated microglia. J Neurochem 1997; 69: 2096-2101
    CrossrefPubMedGoogle Scholar
  • 49 Lv J, Liu F. The role of serotonin beyond the central nervous system during embryogenesis. Front Cell Neurosci 2017; 11: 74
    PubMedGoogle Scholar
  • 50 Herr N, Bode C, Duerschmied D. The effects of serotonin in immune cells. Front Cardiovasc Med 2017; 4: 48i https://doi.org/10.3389/fcvm.2017.00048
    CrossrefPubMedGoogle Scholar
  • 51 Dar NJ, Bhat JA, Satti NK. et al. Withanone, an active constituent from Withania somnifera, affords protection against NMDA-induced excitotoxicity in neuron-like cells. Mol Neurobiol 2017; 54: 5061-5073 https://doi.org/10.1007/s12035-016-0044-7; PMID: 27541286
    CrossrefPubMedGoogle Scholar
  • 52 Bhattacharya SK, Satyan KS, Ghosal S. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J Exp Biol 1997; 35: 236-239 PMID: 9332168
    PubMedGoogle Scholar
  • 53 Ahmad T, Suzuki YJ. Juglone in oxidative stress and cell signaling. Antioxidants (Basel) 2019; 8: 91
    CrossrefPubMedGoogle Scholar
  • 54 Hukema RK, Rademakers S, Jansen G. Gustatory plasticity in C. elegans involves integration of negative cues and NaCl taste mediated by serotonin, dopamine, and glutamate. Learn Mem 2008; 15: 829-836
    CrossrefPubMedGoogle Scholar
  • 55 Martinière A, Fiche JB, Smokvarska M. et al. Osmotic stress activates two reactive oxygen species pathways with distinct effects on protein nanodomains and diffusion. Plant Physiol 2019; 179: 1581-1593
    CrossrefPubMedGoogle Scholar
  • 56 Tatum MC, Ooi FK, Chikka MR. et al. Neuronal serotonin release triggers the heat shock response in C. elegans in the absence of temperature increase. Curr Biol 2015; 25: 163-174
    CrossrefPubMedGoogle Scholar
  • 57 Slimen IB, Najar T, Ghram A. et al. Reactive oxygen species, heat stress and oxidative-induced mitochondrial damage. A review. Int J Hyperthermia 2014; 30: 513-523
    CrossrefPubMedGoogle Scholar
  • 58 Yu Y-B, Dosanjh L, Lao L. et al. Cinnamomum cassia bark in two herbal formulas increases life span in Caenorhabditis elegans via insulin signaling and stress response pathways. PLoS One 2010; 5: e9339
    CrossrefPubMedGoogle Scholar
  • 59 Murakami H, Murakami S. Serotonin receptors antagonistically modulate Caenorhabditis elegans longevity. Aging Cell 2007; 6: 483-488
    CrossrefPubMedGoogle Scholar
  • 60 Nikiforuk A. Targeting the Serotonin 5-HT7 Receptor in the search for treatments for CNS disorders: Rationale and progress to date. CNS Drugs 2015; 29: 265-275
    CrossrefPubMedGoogle Scholar
  • 61 Petrascheck M, Ye X, Buck LB. An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature 2007; 450: 553-556
    CrossrefPubMedGoogle Scholar
  • 62 Kumar R, Gupta K, Saharia K. et al. Withania somnifera root extract extends lifespan of Caenorhabditis elegans. Ann Neurosci 2013; 20: 13-16
    CrossrefPubMedGoogle Scholar
  • 63 Larsen PL. Aging and resistance to oxidative damage in Caenorhabditis elegans. Proc Natl Acad Sci USA 1993; 90: 8905-8909
    CrossrefPubMedGoogle Scholar
  • 64 Wang H, Liu J, Li T. et al. Blueberry extract promotes longevity and stress tolerance via DAF-16 in Caenorhabditis elegans. Food Funct 2018; 9: 5273-5282 https://doi.org/10.1039/c8fo01680a
    CrossrefPubMedGoogle Scholar
  • 65 Wiegant FA, Surinova S, Ytsma E. et al. Plant adaptogens increase lifespan and stress resistance in C. elegans. Biogerontology 2009; 10: 27-42
    CrossrefPubMedGoogle Scholar